how much are glp 1 out of pocket GLP-1 RA prior authorization and out-of-pocket costs rise from 2020 to 2025 Disparities in GLP-1 RA Prescription
Description
At 40 weeks, there was a mean weight reduction of -7.6 kg, -9.3 kg, and -11.2 kg at the 5 mg, 10 mg and 15 mg dose, respectively, while a mean reduction of -5.7 kg with semaglutide 1 mg
A separate overview of leading GLP-1 weight loss programs for 2026 offers broader category context for consumers comparing telehealth access models
Drugs like exenatide, dapagliflozin, and phentermine/topiramate are tested for their weight loss and insulin-sensitizing effects
OBES SURG 30 , 35613569 (2020)
There are also no current plans to create tirzepatide tablets
